Evaluation of Colchicine and Nonsteroidal Anti-inflammatory Drug Combination Therapy and Renal Function in Gout Patients
NCT ID: NCT05006001
Last Updated: 2021-08-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
2000 participants
OBSERVATIONAL
2012-01-01
2024-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prednisolone Versus Colchicine for Acute Gout in Primary Care
NCT05698680
Relation Between Blood Concentration of Colchicine and Response to Colchicine Treatment in Gout Flare
NCT03933007
MPC-004 for the Treatment of an Acute Gout Flare
NCT00506883
Safety & Efficacy of Canakinumab (ACZ885) in Patients With Frequent Flares for Whom Nonsterodial Anti-Inflammatory Drug (NSAIDs) and/ or Colchicine Are Contraindicated, Not Tolerated or Ineffective
NCT01362608
An Innovative Chinese Herbal Formula for the Treatment of Gout
NCT05499312
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Objectives: This proposal will assess the association between colchicine and NSAIDs combination therapy and acute kidney injury. The investigators further evaluate the relationships of duration-response, recency-response, and dose-response.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Case
Cases were defined as patients with an event of renal impairment during follow-up, such as acute kidney injury.
Colchicine and NSAID
Colchicine and nonsteroidal anti-inflammatory drug combination therapy
Control
Cases were defined as patients without an event of renal impairment during follow-up, such as acute kidney injury.
Colchicine and NSAID
Colchicine and nonsteroidal anti-inflammatory drug combination therapy
Exposure
Exposure was defined as patients with colchicine and NSAIDs combination therapy.
No interventions assigned to this group
Non-Exposure
Non-Exposure was defined as patients with other gout therapy.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Colchicine and NSAID
Colchicine and nonsteroidal anti-inflammatory drug combination therapy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Initially receiving at least one anti-gout drug
Exclusion Criteria
* Colchicine and NSAID use before the cohort entry date
* Patients with hemodialysis or peritoneal dialysis before the cohort entry date
* Patients with acute kidney injury before the cohort entry date
20 Years
100 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
En Chu Kong Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ya-Ling Huang
Principal Investigator
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EnChuKongH
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.